La epilepsia refractaria al tratamiento continúa siendo un desafío | Med. infant;29(3): 188-189, Septiembre 2022. | LILACS | UNISALUD | BINACIS

Main content 1 Search 2 Footer 3

+A A -A High contrast

La epilepsia refractaria al tratamiento continúa siendo un desafío / Treatment-resistant epilepsy remains a challenge

Comité Editor.

Med. infant ; 29(3): 188-189, Septiembre 2022.

Article in Es | LILACS, UNISALUD, BINACIS | ID: biblio-1399555

Responsible library: AR305.1

Localization: AR305.1

Subject(s)

Humans; Cannabinoids/therapeutic use; Vagus Nerve Stimulation; Drug Resistant Epilepsy/diet therapy; Drug Resistant Epilepsy/drug therapy; Drug Resistant Epilepsy/therapy; Anticonvulsants/therapeutic use; Chronic Disease

Search on Google

Full text: 1 Index: LILACS Main subject: Cannabinoids / Vagus Nerve Stimulation / Drug Resistant Epilepsy / Anticonvulsants Limits: Humans Language: Es Journal: Med. infant Journal subject: PEDIATRIA Year: 2022 Type: Article

Search on Google

Full text: 1 Index: LILACS Main subject: Cannabinoids / Vagus Nerve Stimulation / Drug Resistant Epilepsy / Anticonvulsants Limits: Humans Language: Es Journal: Med. infant Journal subject: PEDIATRIA Year: 2022 Type: Article